Vyxeos, a revolutionary AML treatment, combines daunorubicin and cytarabine in a liposomal formulation for enhanced efficacy and targeted delivery. Impomed Healthcare makes this advanced therapy Liposomal Daunorubicin & Cytarabine (Vyxeos) in India accessible in India, offering hope and improved outcomes for high-risk AML patients. For more information click on this link-:https://www.impomedhealthcare.com/